Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MK 8776

X
Drug Profile

MK 8776

Alternative Names: MK-8776; SCH 900776

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Schering-Plough
  • Developer Merck & Co
  • Class Antineoplastics; Pyrazoles; Pyrimidines
  • Mechanism of Action Cell cycle inhibitors; Checkpoint kinase 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Cancer; Lymphoma; Solid tumours

Most Recent Events

  • 01 May 2013 Phase-II clinical trials in Acute myeloid leukaemia (combination therapy) in USA (IV)
  • 21 Feb 2012 Schering-Plough terminates a phase I trial in Leukaemia (combination therapy) in USA (NCT00907517)
  • 22 Jun 2011 Schering-Plough completes a phase I trial in Solid tumours and Lymphomas (combination therapy) in US (NCT00779584)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top